Skip to main content
OpenTrials
Completed

NCT Number: NCT02444273

The Feasibility of a Prehabilitation Program in the Liver Transplant Population at Barnes-Jewish Hospital

The primary outcome of this study is to demonstrate the feasibility of a prehabilitation program at Barnes Jewish Hospital for liver transplant candidates. Those patients who consent to participate in the study and are placed on the transplant list will be randomized into either the control or intervention group. The intervention group receives a personalized home exercise program along with weekly phone calls to provide coaching, mentoring and motivation. Data collected at baseline, post-transplant and, post-transplant follow up will be compared among the two study groups. The secondary outcomes include: normative data of functional measures for patients with end stage liver disease and to determine the effect size for future research on prehabilitation in the patient population.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being evaluated for liver transplantation by Barnes Jewish Hospital medical team

Exclusion criteria

  • Non-english speaking
  • Medical contraindications to exercise as determined by the medical team

Treatment and study plan

Exercise

Procedure

Subjects will be given and individualized exercise program.

Primary outcomes

  1. Feasibility of a prehabilitation program.

    Time frame: 2 Years

    Feasibility will be measured by participation and outcome assessment measures.

Secondary outcomes

  1. Normative data on Timed Up and Go for patients with end stage liver disease.

    Time frame: Baseline

  2. Normative data on 10 meter walk for patients with end stage liver disease.

    Time frame: Baseline

  3. Normative data on Modified Dynamic Gait Index for patients with end stage liver disease.

    Time frame: Baseline

  4. Normative data on Five Time Sit to Stand for patients with end stage liver disease.

    Time frame: Baseline

  5. Normative data on 6 Minute Walk Test for patients with end stage liver disease.

    Time frame: Baseline

Sponsors and collaborators

Lead sponsor

Washington University School of Medicine

Other

Collaborators

  • Barnes-Jewish Hospital

Registry information

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
May 14, 2015
Registry last updated
May 11, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.